Refine your search
225 trials found
All(225)
Recruiting(191)
Not yet recruiting(34)
Recruiting
NCT04657991
A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma
Melanoma
Male or Female
18+ years
436study location(s)
Recruiting
NCT05217446
A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
Male or Female
16+ years
202study location(s)
Recruiting
NCT05895786
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
Myositis
Male or Female
18+ years
18study location(s)
Recruiting
NCT05548127
TACTIVE-U: A Study to Learn About the Study Medicine (Called ARV-471) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)
Breast Cancer
Male or Female
18+ years
13study location(s)
Recruiting
NCT04553133
PF-07104091 as a Single Agent and in Combination Therapy
Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer
Male or Female
18+ years
80study location(s)
Recruiting
NCT05487040
A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease
COVID-19
Male or Female
18+ years
88study location(s)
Recruiting
NCT05156398
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Migraine
Male or Female
6 - 17 years
160study location(s)
Recruiting
NCT05995964
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Atopic Dermatitis
Male or Female
18+ years
32study location(s)
Recruiting
NCT04029480
Ertugliflozin Pidolate Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)
Type 2 Diabetes Mellitus
Male or Female
10 - 17 years
59study location(s)
Recruiting
NCT05842967
A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV Disease
RESPIRATORY SYNCYTIAL VIRUS (RSV)
Male or Female
18+ years
76study location(s)
Saved trials
Saved trials
You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.
All(225)
Recruiting(191)
Not yet recruiting(34)
Contact us
For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.